Alzheimer's disease is one of the world's biggest health problems. Yet, despite the fact millions of people globally are ...

Researchers have revealed the role of enzyme TYK2 in the aggregation of tau proteins, which contributes to Alzheimer’s ...

Researchers at Baylor College of Medicine, the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas ...

test reliably predicted regional tau accumulation in early Alzheimer's disease and could reduce reliance on tau PET scans. (Alzheimer's and Dementia) Younger patients were disproportionately ...

Eli Lilly is still celebrating the FDA approval of its amyloid-directed Alzheimer's therapy Kisunla but has had less fortune with a candidate against tau, another well-established drug target for ...

“Because of the prevalence of both TBI and Alzheimer’s in humans ... a protein involved in protein clearance through the autophagy-lysosome pathway, contributes to the accumulation of ...

The week after seeing its partner Roche cut and run, UCB has reported the failure of its anti-tau antibody bepranemab to improve cognition and function in people with early Alzheimer’s disease.

"Because of the prevalence of both TBI and Alzheimer's in humans ... through the autophagy-lysosome pathway, contributes to the accumulation of hyperphosphorylated tau in neurons and ...

Because of the prevalence of both TBI and Alzheimer's in humans ... through the autophagy-lysosome pathway, contributes to the accumulation of hyperphosphorylated tau in neurons and ...